ÂÜÀòÂÒÂ×

John Tchelingerian, PhD, is a distinguished entrepreneur and investor with extensive experience in the fields of pharmaceuticals, biotechnology, and sustainable technology. As the Founder, Managing Partner, and Chairman of The Connecting Architects since January 2021, John Tchelingerian supports innovative companies with strategic business development and growth advisory services. In addition to advisory roles at multiple biopharma startups, including PannTheraPi, Peptitech, Amaros AI, and Rtec, John Tchelingerian's leadership extends to positions such as Chairman of the Board at Antion Biosciences SA and Chairman of the Supervisory Board at Pan Cancer T. John Tchelingerian co-founded MELKIN PHARMACEUTICALS in 2015, enhancing investment efforts in SCI-BRAIN since 2017, and has been actively involved in venture capital through Silver Ocean Ventures since 2009. John Tchelingerian's academic background includes a PhD in Neurosciences from Pierre and Marie Curie University, specializing in neural transplants, neuro-immunology, and cell therapy.